Prime Medicine, Inc.

Q2 2026 13F Holders

Symbol
PRME
CUSIP
74168J101
Type
Equity
Class
COM
Num filings
196
Total reported value, excl. options
$551 M
Manager Report Date Value ($000) Shares Option Type